Medical Students' Exposure to and Attitudes About Drug Company Interactions
暂无分享,去创建一个
J. Chao | W. Shore | J. Frank | F. Sierles | Amy C. Brodkey | Lynn M. Cleary | D. J. Lynn | Bruce Z. Morgenstern | John L. Woodard
[1] Amy C. Brodkey. The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem , 2005, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.
[2] M. Bellin,et al. Medical Students’ Exposure to Pharmaceutical Industry Marketing: A Survey at One U.S. Medical School , 2004, Academic medicine : journal of the Association of American Medical Colleges.
[3] D. Blumenthal. Doctors and drug companies. , 2004, The New England journal of medicine.
[4] R. Kravitz,et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[5] T. Walley,et al. Influences on GPs' decision to prescribe new drugs-the importance of who says what. , 2003, Family practice.
[6] C. Gross,et al. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. , 2003, JAMA.
[7] S. Peiró,et al. Accuracy of pharmaceutical advertisements in medical journals , 2003, The Lancet.
[8] K. Galt,et al. Student Understanding of the Relationship Between the Health Professions and the Pharmaceutical Industry , 2003, Teaching and learning in medicine.
[9] R. Califf,et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. , 2002, The New England journal of medicine.
[10] A. Detsky,et al. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. , 2002, JAMA.
[11] A S Detsky,et al. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. , 2001, JAMA.
[12] S. Mcphee,et al. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. , 2001, The American journal of medicine.
[13] A. Relman,et al. Separating continuing medical education from pharmaceutical marketing. , 2001, JAMA.
[14] T. Bodenheimer,et al. Uneasy alliance--clinical investigators and the pharmaceutical industry. , 2000, The New England journal of medicine.
[15] A. Wazana,et al. Physicians and the pharmaceutical industry: is a gift ever just a gift? , 2000, JAMA.
[16] David Siegel,et al. Trends in Antihypertensive Drug Use in the United States: Do the JNC V Recommendations Affect Prescribing? , 1997 .
[17] W. Sandberg,et al. The Effect of Educational Gifts from Pharmaceutical Firms on Medical Students' Recall of Company Names or Products , 1997, Academic medicine : journal of the Association of American Medical Colleges.
[18] D. Stryer,et al. Characteristics of materials distributed by drug companies , 1996, Journal of General Internal Medicine.
[19] W P McKinney,et al. Physicians, pharmaceutical sales representatives, and the cost of prescribing. , 1996, Archives of family medicine.
[20] D. Rennie,et al. Influences on the Quality of Published Drug Studies , 1996, International Journal of Technology Assessment in Health Care.
[21] M. Cho,et al. The Quality of Drug Studies Published in Symposium Proceedings , 1996, Annals of Internal Medicine.
[22] J. Berlin,et al. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? , 1996, Academic medicine : journal of the Association of American Medical Colleges.
[23] B. Hodges,et al. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[24] M. Ziegler,et al. The accuracy of drug information from pharmaceutical sales representatives. , 1995, JAMA.
[25] M. Chren,et al. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. , 1994, JAMA.
[26] D B Witzke,et al. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. , 1993, Annals of emergency medicine.
[27] L. White,et al. Pharmaceutical representatives and emergency medicine residents: a national survey. , 1993, Annals of emergency medicine.
[28] D. Mark,et al. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities , 1993, Journal of General Internal Medicine.
[29] A G Mainous,et al. Attitudes of medical school faculty toward gifts from the pharmaceutical industry , 1992, Academic medicine : journal of the Association of American Medical Colleges.
[30] J. Orlowski,et al. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. , 1992, Chest.
[31] W P McKinney,et al. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. , 1990, Journal of the American Medical Association (JAMA).
[32] Bower Ad,et al. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. , 1987 .
[33] R Hartley,et al. Scientific versus commercial sources of influence on the prescribing behavior of physicians. , 1982, The American journal of medicine.
[34] Sebastian Schneeweiss,et al. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. , 2005, Journal of clinical epidemiology.
[35] D. Vinson,et al. Medical students' attitudes toward pharmaceutical marketing: possibilities for change. , 1993, Family medicine.
[36] M. Bowman,et al. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. , 1988, The Journal of continuing education in the health professions.
[37] Marjorie A. Bowman,et al. The impact of drug company funding on the content of continuing medical education , 1986 .
[38] F Haayer,et al. Rational prescribing and sources of information. , 1982, Social science & medicine.